Global Dermatology Biologics Market Research Report 2023

Publisher Name :
Date: 20-Jan-2023
No. of pages: 83
Inquire Before Buying

Highlights

The global Dermatology Biologics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Dermatology Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Dermatology Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Dermatology Biologics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Dermatology Biologics include Merck and Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Amgen Inc., AstraZenca, Celgene Corporation, Eli Lilly and Company and Johnson and Johnson (Janssen Biotech Inc.), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatology Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology Biologics.

The Dermatology Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dermatology Biologics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dermatology Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Merck and Co. Inc.

- Novartis AG

- Pfizer Inc.

- AbbVie Inc.

- Amgen Inc.

- AstraZenca

- Celgene Corporation

- Eli Lilly and Company

- Johnson and Johnson (Janssen Biotech Inc.)

Segment by Type

- Interleukin Inhibitors

- Tumor Necrosis Factor Inhibitors

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- E-Commerce

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatology Biologics companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Dermatology Biologics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatology Biologics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Interleukin Inhibitors
1.2.3 Tumor Necrosis Factor Inhibitors
1.3 Market by Application
1.3.1 Global Dermatology Biologics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatology Biologics Market Perspective (2018-2029)
2.2 Dermatology Biologics Growth Trends by Region
2.2.1 Global Dermatology Biologics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Dermatology Biologics Historic Market Size by Region (2018-2023)
2.2.3 Dermatology Biologics Forecasted Market Size by Region (2024-2029)
2.3 Dermatology Biologics Market Dynamics
2.3.1 Dermatology Biologics Industry Trends
2.3.2 Dermatology Biologics Market Drivers
2.3.3 Dermatology Biologics Market Challenges
2.3.4 Dermatology Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatology Biologics Players by Revenue
3.1.1 Global Top Dermatology Biologics Players by Revenue (2018-2023)
3.1.2 Global Dermatology Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Dermatology Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatology Biologics Revenue
3.4 Global Dermatology Biologics Market Concentration Ratio
3.4.1 Global Dermatology Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatology Biologics Revenue in 2022
3.5 Dermatology Biologics Key Players Head office and Area Served
3.6 Key Players Dermatology Biologics Product Solution and Service
3.7 Date of Enter into Dermatology Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatology Biologics Breakdown Data by Type
4.1 Global Dermatology Biologics Historic Market Size by Type (2018-2023)
4.2 Global Dermatology Biologics Forecasted Market Size by Type (2024-2029)
5 Dermatology Biologics Breakdown Data by Application
5.1 Global Dermatology Biologics Historic Market Size by Application (2018-2023)
5.2 Global Dermatology Biologics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Dermatology Biologics Market Size (2018-2029)
6.2 North America Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Dermatology Biologics Market Size by Country (2018-2023)
6.4 North America Dermatology Biologics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatology Biologics Market Size (2018-2029)
7.2 Europe Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Dermatology Biologics Market Size by Country (2018-2023)
7.4 Europe Dermatology Biologics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Biologics Market Size (2018-2029)
8.2 Asia-Pacific Dermatology Biologics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Dermatology Biologics Market Size by Region (2018-2023)
8.4 Asia-Pacific Dermatology Biologics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatology Biologics Market Size (2018-2029)
9.2 Latin America Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Dermatology Biologics Market Size by Country (2018-2023)
9.4 Latin America Dermatology Biologics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Biologics Market Size (2018-2029)
10.2 Middle East & Africa Dermatology Biologics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Dermatology Biologics Market Size by Country (2018-2023)
10.4 Middle East & Africa Dermatology Biologics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck and Co. Inc.
11.1.1 Merck and Co. Inc. Company Detail
11.1.2 Merck and Co. Inc. Business Overview
11.1.3 Merck and Co. Inc. Dermatology Biologics Introduction
11.1.4 Merck and Co. Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.1.5 Merck and Co. Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Dermatology Biologics Introduction
11.2.4 Novartis AG Revenue in Dermatology Biologics Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Dermatology Biologics Introduction
11.3.4 Pfizer Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.3.5 Pfizer Inc. Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Detail
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Dermatology Biologics Introduction
11.4.4 AbbVie Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.4.5 AbbVie Inc. Recent Development
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Detail
11.5.2 Amgen Inc. Business Overview
11.5.3 Amgen Inc. Dermatology Biologics Introduction
11.5.4 Amgen Inc. Revenue in Dermatology Biologics Business (2018-2023)
11.5.5 Amgen Inc. Recent Development
11.6 AstraZenca
11.6.1 AstraZenca Company Detail
11.6.2 AstraZenca Business Overview
11.6.3 AstraZenca Dermatology Biologics Introduction
11.6.4 AstraZenca Revenue in Dermatology Biologics Business (2018-2023)
11.6.5 AstraZenca Recent Development
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Detail
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Dermatology Biologics Introduction
11.7.4 Celgene Corporation Revenue in Dermatology Biologics Business (2018-2023)
11.7.5 Celgene Corporation Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Detail
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Dermatology Biologics Introduction
11.8.4 Eli Lilly and Company Revenue in Dermatology Biologics Business (2018-2023)
11.8.5 Eli Lilly and Company Recent Development
11.9 Johnson and Johnson (Janssen Biotech Inc.)
11.9.1 Johnson and Johnson (Janssen Biotech Inc.) Company Detail
11.9.2 Johnson and Johnson (Janssen Biotech Inc.) Business Overview
11.9.3 Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Introduction
11.9.4 Johnson and Johnson (Janssen Biotech Inc.) Revenue in Dermatology Biologics Business (2018-2023)
11.9.5 Johnson and Johnson (Janssen Biotech Inc.) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Dermatology Biologics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Interleukin Inhibitors
Table 3. Key Players of Tumor Necrosis Factor Inhibitors
Table 4. Global Dermatology Biologics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Dermatology Biologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Dermatology Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Dermatology Biologics Market Share by Region (2018-2023)
Table 8. Global Dermatology Biologics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Dermatology Biologics Market Share by Region (2024-2029)
Table 10. Dermatology Biologics Market Trends
Table 11. Dermatology Biologics Market Drivers
Table 12. Dermatology Biologics Market Challenges
Table 13. Dermatology Biologics Market Restraints
Table 14. Global Dermatology Biologics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Dermatology Biologics Market Share by Players (2018-2023)
Table 16. Global Top Dermatology Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Biologics as of 2022)
Table 17. Ranking of Global Top Dermatology Biologics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Dermatology Biologics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatology Biologics Product Solution and Service
Table 21. Date of Enter into Dermatology Biologics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatology Biologics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Dermatology Biologics Revenue Market Share by Type (2018-2023)
Table 25. Global Dermatology Biologics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Dermatology Biologics Revenue Market Share by Type (2024-2029)
Table 27. Global Dermatology Biologics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Dermatology Biologics Revenue Market Share by Application (2018-2023)
Table 29. Global Dermatology Biologics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Dermatology Biologics Revenue Market Share by Application (2024-2029)
Table 31. North America Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Dermatology Biologics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Dermatology Biologics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Dermatology Biologics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Dermatology Biologics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Dermatology Biologics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Dermatology Biologics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Dermatology Biologics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Dermatology Biologics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Dermatology Biologics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Merck and Co. Inc. Company Detail
Table 47. Merck and Co. Inc. Business Overview
Table 48. Merck and Co. Inc. Dermatology Biologics Product
Table 49. Merck and Co. Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 50. Merck and Co. Inc. Recent Development
Table 51. Novartis AG Company Detail
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Dermatology Biologics Product
Table 54. Novartis AG Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 55. Novartis AG Recent Development
Table 56. Pfizer Inc. Company Detail
Table 57. Pfizer Inc. Business Overview
Table 58. Pfizer Inc. Dermatology Biologics Product
Table 59. Pfizer Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 60. Pfizer Inc. Recent Development
Table 61. AbbVie Inc. Company Detail
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. Dermatology Biologics Product
Table 64. AbbVie Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. Amgen Inc. Company Detail
Table 67. Amgen Inc. Business Overview
Table 68. Amgen Inc. Dermatology Biologics Product
Table 69. Amgen Inc. Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 70. Amgen Inc. Recent Development
Table 71. AstraZenca Company Detail
Table 72. AstraZenca Business Overview
Table 73. AstraZenca Dermatology Biologics Product
Table 74. AstraZenca Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 75. AstraZenca Recent Development
Table 76. Celgene Corporation Company Detail
Table 77. Celgene Corporation Business Overview
Table 78. Celgene Corporation Dermatology Biologics Product
Table 79. Celgene Corporation Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 80. Celgene Corporation Recent Development
Table 81. Eli Lilly and Company Company Detail
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Dermatology Biologics Product
Table 84. Eli Lilly and Company Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Johnson and Johnson (Janssen Biotech Inc.) Company Detail
Table 87. Johnson and Johnson (Janssen Biotech Inc.) Business Overview
Table 88. Johnson and Johnson (Janssen Biotech Inc.) Dermatology Biologics Product
Table 89. Johnson and Johnson (Janssen Biotech Inc.) Revenue in Dermatology Biologics Business (2018-2023) & (US$ Million)
Table 90. Johnson and Johnson (Janssen Biotech Inc.) Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology Biologics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Dermatology Biologics Market Share by Type: 2022 VS 2029
Figure 3. Interleukin Inhibitors Features
Figure 4. Tumor Necrosis Factor Inhibitors Features
Figure 5. Global Dermatology Biologics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Dermatology Biologics Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. E-Commerce Case Studies
Figure 10. Dermatology Biologics Report Years Considered
Figure 11. Global Dermatology Biologics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Dermatology Biologics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Dermatology Biologics Market Share by Region: 2022 VS 2029
Figure 14. Global Dermatology Biologics Market Share by Players in 2022
Figure 15. Global Top Dermatology Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology Biologics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Dermatology Biologics Revenue in 2022
Figure 17. North America Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Dermatology Biologics Market Share by Country (2018-2029)
Figure 19. United States Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Dermatology Biologics Market Share by Country (2018-2029)
Figure 23. Germany Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Dermatology Biologics Market Share by Region (2018-2029)
Figure 31. China Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Dermatology Biologics Market Share by Country (2018-2029)
Figure 39. Mexico Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Dermatology Biologics Market Share by Country (2018-2029)
Figure 43. Turkey Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Dermatology Biologics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Merck and Co. Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 46. Novartis AG Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 47. Pfizer Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 48. AbbVie Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 49. Amgen Inc. Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 50. AstraZenca Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 51. Celgene Corporation Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 53. Johnson and Johnson (Janssen Biotech Inc.) Revenue Growth Rate in Dermatology Biologics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
  • Global Positive Airway Pressure (PAP) Machines Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 98
    Highlights The global Positive Airway Pressure (PAP) Machines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Positive Airway Pressure (PAP) Machines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the ......
  • Global Sleep Apnea Solutions Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 92
    Highlights The global Sleep Apnea Solutions market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Sleep Apnea Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029......
  • Global At-home DNA Tests Kits Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 90
    At-home DNA tests kits can provide a wealth of information about your genetic makeup, health, disease risk, and ancestry. They can also help you connect with relatives and build out your family tree. Highlights The global At-home DNA Tests Kits market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating......
  • Global Diabetes Testing Kit Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 99
    Highlights The global Diabetes Testing Kit market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Diabetes Testing Kit is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Germicidal UV Striplight Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 93
    Fail-Safe GUV Disinfecting Solutions, germicidal UV (GUV) fixtures use ultraviolet radiant energy to inactivate bacteria, mold spores, fungi or viruses. Highlights The global Germicidal UV Striplight market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market f......
  • Global Female External Urinary Devices Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 98
    Highlights The global Female External Urinary Devices market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Female External Urinary Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period ......
  • Global Urinary Incontinence Repair Surgical Sling Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 92
    Highlights The global Urinary Incontinence Repair Surgical Sling market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Urinary Incontinence Repair Surgical Sling is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % durin......
  • Global Female Urinary Incontinence Treatment Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 101
    Highlights The global Female Urinary Incontinence Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Female Urinary Incontinence Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the fore......
  • Global External Urine Collection Device Market Research Report 2023
    Published: 24-Jan-2023        Price: US 2900 Onwards        Pages: 87
    Highlights The global External Urine Collection Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for External Urine Collection Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast perio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs